Navigation Links
Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
Date:5/11/2009

TORONTO, and CHENNAI, India, May 11 /PRNewswire/ -- Dalton Pharma Services and ProCitius Research jointly announce a strategic alliance created to provide clients with contract chemistry services of exceptional value.

Global pharmaceutical companies, in order to maintain their discovery and development output in an era of severe cost restraints, have been increasing their use of "offshore" contract research organizations (CROs) in countries such as China and India. Despite the quality of chemists in offshore CROs, there are often performance issues caused by communication and cultural differences. In order to ensure quality and timeliness in the contracted work, pharmaceutical companies are usually forced to dedicate senior staff to manage these projects on-site or from Western research centers.

Dalton and ProCitius have teamed up to offer clients the best of both worlds. Projects carried out by ProCitius in India are tightly controlled by senior Dalton project managers based at the company headquarters in Canada. Clients deal only with Dalton, which assumes full legal and operational responsibility for the satisfactory execution of the contract. The contract pricing is based on attractive FTE rates.

"I believe this type of hybrid service fills an important need in our industry," said Peter Pekos, President and CEO of Dalton Pharma Services. "Over the past two decades I have worked to adjust our service offering to meet the changing requirements of my clients and today's announcement is part of this continuing evolution," he continued. "In ProCitius we have the ideal partner: well-established; large FTE headcount; excellent facilities and infrastructure; robust documentation; and a reputation for high ethical and environmental standards."


'/>"/>
SOURCE Dalton Pharma Services
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
2. Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development
3. BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
4. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
5. BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
6. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
7. Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution
8. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
9. Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
10. PDL BioPharma Announces First Quarter 2009 Financial Results
11. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 PointCross Life ... Ltd. to provide an integrated Big Data and globally ... biomarkers collected in the context of clinical trials and ... precise or multi-targeted drug candidates, stratified patient selection and ... progression free survival. Highlighting the timing ...
(Date:4/20/2015)... ANGELES , April 20, 2015  "Everybody is ... we do to patients is frankly brutal. We,ve got ... in a cancer ward, or witnessed a loved one ... you,ve witnessed firsthand the devastation chemotherapy and other treatments ... most people want to give up and succumb to ...
(Date:4/20/2015)... 2015 /CNW/ - Portage Biotech Inc. ("Portage" or "the ... pleased to announce that its wholly owned subsidiary, Portage ... that showed one of its proprietary human-derived CPP sequences ... through inhibition of NFkB signalling even if administered when ... of the blood brain barrier (BBB) in mice was ...
(Date:4/20/2015)... 20, 2015   Meditope Biosciences, Inc ., a ... technology, today announced presentation of data demonstrating the use ... antibody-drug conjugates (ADCs). The data were presented in an abstract ... 18-22 in Philadelphia . ... point to the many commercial applications that may be ...
Breaking Biology Technology:PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development 2Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2
... (Nasdaq: ERES ) announced today that it will ... 2010 Tuesday, March 1, after the market closes. After the ... PM ET that day. For the conference ... United States or 1-412-858-4600 when calling internationally. There will be ...
... Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today ... BIO CEO & Investor Conference on Monday, February 14, ... the Waldorf=Astoria Hotel in New York City. Jack Lief, Arena,s President ... A live audio webcast of the presentation will be ...
... Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) ... its financial statements as of December 31, 2009 and 2010 ... "Top 25 Firms" by Inside Public Accounting , Marcum ... than 150 partners, in 23 offices throughout New York, New ...
Cached Biology Technology:ERT Reports Fourth Quarter and Full Year 2010 Operating Results on March 1, 2011 2Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference 2Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference 3Stem Cell Assurance Announces Engagement of Marcum LLP as its Independent Auditors 2
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
(Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... wallet is one of the products featured in 2015 ... 20th at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... Energy Secretary Steven Chu announced today that more than ... and Reinvestment Act will go toward scientific research, instrumentation, ... in six states will be receiving funds, along with ... "These new initiatives will help to create ...
... antibiotic drought, scientists in Massachusetts are describing successful use ... to discover badly needed new antibiotics. Their study appeared ... Frederick Ausubel and colleagues note in the ... involve adding the potential drug to cultures of bacteria ...
... the world,s environment ministers, government officials, diplomats and campaigners ... December 2009 to unite in the battle against climate ... the world has ever seen, the increasingly complex territory ... published today, 5 August, 2009, in IOP Publishing,s ...
Cached Biology News:Obama administration announces more than $327 million in Recovery Act funding for science research 2Obama administration announces more than $327 million in Recovery Act funding for science research 3Climate change poker: The barriers which are preventing a global agreement 2
...
... Ideal for relax positively and negatively supercoiled ... , Studying the effects of supercoiling ... reconstitution in vitro , Determining the degree ... Detecting mutant plasmids that differ in length by ...
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
Immunogen: Synthetic peptide (KLH conjugated): L(506) S K S S S Q I R M S G L P A D N L A T(525) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: